Efficacy of Rimonabant and Other Cannabinoid CB(1) Receptor Antagonists in Reducing Food Intake and Body Weight: Preclinical and Clinical Data

The present paper focuses on the different lines of evidence indicating that cannabinoid CB(1) receptor antagonists, including the prototype rimonabant, reduce food intake and body weight in laboratory animals. Recent clinical surveys demonstrated that rimonabant significantly reduced body weight al...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Drug Rev
Main Authors: Carai, Mauro A. M., Colombo, Giancarlo, Maccioni, Paola, Gessa, Gian Luigi
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Inc 2006
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494144/
https://ncbi.nlm.nih.gov/pubmed/16958983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2006.00091.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados